Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media

Clinical and Experimental Immunology

Volumn 144, Issue 1, 2006, Pages 158-168

  Gallot, G ^a   Vollant, S ^a   Vivien, R ^a   Clemenceau B ^a   Ferrand, C ^a   Tiberghien, P ^a   Gaschet, J ^b   Robillard, N ^b   Vie H ^a,b  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Antigen presentation; BLCL; CTL line; EBV; FCS

Indexed keywords

ANTIGEN; CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL HETEROGENEITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; DONOR; EPSTEIN BARR VIRUS; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SERODIAGNOSIS; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; CULTURE MEDIA, SERUM-FREE; CYTOKINES; EPITOPES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33645103732     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03035.x     Document Type: Article

References (37)

1. Rickinson AB Kieff E Epstein-Barr virus In Fields BN Knipe DM Howley PM Griffin DE Lamb RA Martin MA Roitzman B Strauss SE eds Fields Virology 4th edn Philadelphia: Lippincott. Williams & Wilkins 2001 2575 627
2. Pope JH Horne MK Scott W Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus Int J Cancer 1968 3 857 66
3. Amyes E Hatton C Montamat-Sicotte D et al. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection J Exp Med 2003 198 903 11
4. Moreau JF Bonneville M Peyrat MA et al. T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis J Clin Invest 1986 78 874 9
5. Rickinson AB Moss DJ Allen DJ Wallace LE Rowe M Epstein MA Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line Int J Cancer 1981 27 593 601
6. Retiere C Prod'homme V Imbert-Marcille BM Bonneville M Vie H Hallet MM Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response J Virol 2000 74 3948 52
7. Lucas KG Sun Q Burton RL et al. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants Hum Gene Ther 2000 11 1453 63
8. Wroblewski JM Copple A Batson LP Landers CD Yannelli JR Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs) J Immunol Meth 2002 264 19 28
9. Misko IS Soszynski TD Kane RG Pope JH Factors influencing the human cytotoxic T cell response to autologous lymphoblastoid cell lines in vitro Clin Immunol Immunopathol 1984 32 285 97
10. Misko IS Kane RG Pope JH Generation in vitro of EBV-induced specific cytotoxic T cells in autologous serum avoids complications due to self-preferred foetal calf serum-specific T-cell cytotoxicity Int J Cancer 1981 27 513 9
11. Omiya R Buteau C Kobayashi H Paya CV Celis E Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope J Immunol 2002 169 2172 9
12. Miller G Shope T Lisco H Stitt D Lipman M Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes Proc Natl Acad Sci USA 1972 69 383 7
13. Cook EB Stahl JL Lowe L et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics J Immunol Meth 2001 254 109 18
14. Scotet E David-Ameline J Peyrat MA et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis J Exp Med 1996 184 1791 800
15. Scotet E Peyrat MA Saulquin X et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes Eur J Immunol 1999 29 973 85
16. Brichard V Van Pel A Wolfel T et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 1993 178 489 95
17. Espevik T Nissen-Meyer J A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes J Immunol Meth 1986 95 99 105
18. Precopio ML Sullivan JL Willard C Somasundaran M Luzuriaga K Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection J Immunol 2003 170 2590 8
19. Khanna R Moss DJ Burrows SR Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation Immunol Rev 1999 170 49 64
20. Pothen S Cao T Smith R Levine PH Levine A Pearson GR Identification of T- and B-cell epitopes associated with a restricted component of the Epstein-Barr virus-induced early antigen complex Int J Cancer 1993 53 199 204
21. Landais E Saulquin X Scotet E et al. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1 Blood 2004 103 1408 16
22. White CA Cross SM Kurilla MG et al. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1 Virology 1996 219 489 92
23. Leen A Meij P Redchenko I et al. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses J Virol 2001 75 8649 59
24. Kruger S Schroers R Rooney CM Gahn B Chen SY Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1 J Immunother 2003 26 212 21
25. Paludan C Bickham K Nikiforow S et al. Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells J Immunol 2002 169 1593 603
26. Khanna R Burrows SR Steigerwald-Mullen PM Thomson SA Kurilla MG Moss DJ Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance Virology 1995 214 633 7
27. Voo KS Fu T Heslop HE Brenner MK Rooney CM Wang RF Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells Cancer Res 2002 62 7195 9
28. Khanna R Burrows SR Thomson SA et al. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs J Immunol 1997 158 3619 25
29. Rajnavolgyi E Nagy N Thuresson B et al. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes Int Immunol 2000 12 281 93
30. Zinkernagel RM On cross-priming of MHC class I-specific CTL. rule or exception? Eur J Immunol 2002 32 2385 92
31. Rooney CM Smith CA Ng CY et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation Lancet 1995 345 9 13
32. Heslop HE Ng CY Li C et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes Nat Med 1996 2 551 5
33. Sun Q Burton R Reddy V Lucas KG Safety of allogeneic Epstein-Barr virus (EBV) -specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma Br J Haematol 2002 118 799 808
34. Lucas KG Salzman D Garcia A Sun Q Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease Cancer 2004 100 1892 901
35. Wilkie GM Taylor C Jones MM et al. Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases J Immunother 2004 27 309 16
36. Savoldo B Huls MH Liu Z et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection Blood 2002 100 4059 66
37. Bollard CM Kuehnle I Leen A Rooney CM Heslop HE Adoptive immunotherapy for posttransplantation viral infections Biol Blood Marrow Transplant 2004 10 143 55